To the full analysis
STERIS stock: growth
STESTERIS reported $5.94B in revenue for fiscal 2026, up 8.7% on the prior year, up 13.8% a year on average over up to five years.
Daily figure as of 12 Nov 2026
Revenue (Annual rate)
8.8%
per year from 2007 to 2026, per share 6.5%
Earnings (Annual rate)
12.6%
per year from 2007 to 2026, per share 10.2%
Free cash flow (Annual rate)
17.3%
per year from 2007 to 2026, per share 14.8%
Growth per year by period
What reaches shareholders is growth per share: buybacks lift it, new shares dilute it.
| since 2021 | since 2016 | since 2007 | |
|---|---|---|---|
| Revenue | 13.8% | 10.2% | 8.8% |
| Revenue per share | 10.6% | 6.7% | 6.5% |
| Earnings | 14.6% | 21.6% | 12.6% |
| Earnings per share | 11.2% | 17.6% | 10.2% |
| Free cash flow | 16.6% | 22.5% | 17.3% |
| Free cash flow per share | 13.4% | 18.5% | 14.8% |
Fiscal years at a glance
How revenue and earnings grow
- Revenue
- Earnings
- Free cash flow
Figures as a table
| Year | Revenue | Earnings | Free cash flow |
|---|---|---|---|
| 2007 | $1.2B | $82.16M | $46.72M |
| 2008 | $1.27B | $77.11M | $86.43M |
| 2009 | $1.3B | $110.69M | $126.5M |
| 2010 | $1.26B | $128.47M | $180.87M |
| 2011 | $1.21B | $51.27M | $40.3M |
| 2012 | $1.41B | $136.12M | $82.69M |
| 2013 | $1.5B | $159.98M | $140.4M |
| 2014 | $1.62B | $129.44M | $123.26M |
| 2015 | $1.85B | $135.06M | $160.79M |
| 2016 | $2.24B | $110.76M | $128.27M |
| 2017 | $2.61B | $109.97M | $251.19M |
| 2018 | $2.62B | $290.92M | $292.18M |
| 2019 | $2.78B | $304.05M | $349.79M |
| 2020 | $3.03B | $407.66M | $376.04M |
| 2021 | $3.11B | $397.4M | $450.38M |
| 2022 | $4.22B | $243.89M | $397.25M |
| 2023 | $4.54B | $107.03M | $394.98M |
| 2024 | $5.14B | $378.24M | $612.95M |
| 2025 | $5.46B | $614.64M | $778M |
| 2026 | $5.94B | $785.1M | $972.4M |
Revenue by segment
How STERIS plc makes its money and how that has shifted. Names are as the company reports them.
- Product52%
- Service48%
Figures as a table
| 2024 | 2025 | 2026 | Share 2026 | |
|---|---|---|---|---|
| Product | $2.76B | $2.87B | $3.06B | 51.6% |
| Service | $2.37B | $2.59B | $2.88B | 48.4% |
| Total revenue | $5.14B | $5.46B | $5.94B | 100% |
Revenue by region
Where STERIS plc generates its revenue.
- United States73%
- Ireland2%
- Other25%
“Other” combines smaller regions with revenue the company does not assign to a region.
Figures as a table
| 2024 | 2025 | 2026 | Share 2026 | |
|---|---|---|---|---|
| United States | $3.75B | $4.01B | $4.33B | 73% |
| Ireland | $82.7M | $107.32M | $108.5M | 1.8% |
| Other | $1.3B | $1.34B | $1.49B | 25.2% |
| Total revenue | $5.14B | $5.46B | $5.94B | 100% |
Data status and sources
- Score
- Daily value of 12 Nov 2026, recalculated nightly
- Price
- Closing price of 11 Nov 2026
- Latest annual report
- Fiscal year 2026, period end 31 Mar 2026
- Source
- Financial statements, ratios and prices from Financial Modeling Prep (FMP), based on the company's reports. MEQIRI calculates the score and fair value from them.
Mandatory disclosures for this rating
- ; time horizon around 12 months
- Rated Strong, published since 7 Nov 2026 (in the score history since 5 Nov 2026)
- Valuation signal Fairly valued since 7 Nov 2026
- End-of-day prices, metrics cached for up to 24 hours
- Score and fair value are estimates from a disclosed model. They are not facts and not a price target.
- Produced by SSM Ventures UG (haftungsbeschränkt), responsible person Sven Brostmeyer, Managing Director, automatically according to the disclosed model.
- Not investment advice. Losses up to and including a total loss are possible. Personal circumstances are not considered.